131 related articles for article (PubMed ID: 1701908)
1. [Molecular structure and immunochemistry of streptococcal M-protein].
Ookuni H
Tanpakushitsu Kakusan Koso; 1990 Nov; 35(15):2839-51. PubMed ID: 1701908
[No Abstract] [Full Text] [Related]
2. Group A streptococcal M proteins: virulence factors and protective antigens.
Robinson JH; Kehoe MA
Immunol Today; 1992 Sep; 13(9):362-7. PubMed ID: 1281632
[TBL] [Abstract][Full Text] [Related]
3. Streptococcal defenses against host immune attack: the M protein-fibrinogen interaction.
Whitnack E; Dale JB; Beachey EH
Trans Assoc Am Physicians; 1983; 96():197-202. PubMed ID: 6208666
[No Abstract] [Full Text] [Related]
4. Recombinant tetravalent group A streptococcal M protein vaccine.
Dale JB; Chiang EY; Lederer JW
J Immunol; 1993 Aug; 151(4):2188-94. PubMed ID: 8345202
[TBL] [Abstract][Full Text] [Related]
5. Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein.
Kraus W; Haanes-Fritz E; Cleary PP; Seyer JM; Dale JB; Beachey EH
J Immunol; 1987 Nov; 139(9):3084-90. PubMed ID: 2444650
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of group A streptococci in mice and efficacy of locally administered streptococcal vaccines.
Bronze MS; McKinsey DS; Beachey EH; Dale JB
Trans Assoc Am Physicians; 1988; 101():88-92. PubMed ID: 3077732
[No Abstract] [Full Text] [Related]
7. Protective and heart-cross-reactive epitopes of type 19 streptococcal M protein.
Bronze MS; Beachey EH; Seyer JM; Dale JB
Trans Assoc Am Physicians; 1987; 100():80-4. PubMed ID: 2457979
[No Abstract] [Full Text] [Related]
8. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain.
Bronze MS; Dale JB
J Immunol; 1993 Sep; 151(5):2820-8. PubMed ID: 7689617
[TBL] [Abstract][Full Text] [Related]
9. [Mechanisms and manifestations of population variability in Streptococcus pyogenes].
Kaminskiĭ GD; Beliakov VD
Vestn Akad Med Nauk SSSR; 1986; (7):10-7. PubMed ID: 2428180
[No Abstract] [Full Text] [Related]
10. The common antigen(s) of streptococcal M protein vaccines causing hyperimmune reactions in man.
Beachey EH; Stollerman GH
Trans Assoc Am Physicians; 1972; 85():212-21. PubMed ID: 4121774
[No Abstract] [Full Text] [Related]
11. Role of the hypervariable region in streptococcal M proteins: binding of a human complement inhibitor.
Johnsson E; Berggård K; Kotarsky H; Hellwage J; Zipfel PF; Sjöbring U; Lindahl G
J Immunol; 1998 Nov; 161(9):4894-901. PubMed ID: 9794423
[TBL] [Abstract][Full Text] [Related]
12. Evasion of phagocytosis through cooperation between two ligand-binding regions in Streptococcus pyogenes M protein.
Carlsson F; Berggård K; Stålhammar-Carlemalm M; Lindahl G
J Exp Med; 2003 Oct; 198(7):1057-68. PubMed ID: 14517274
[TBL] [Abstract][Full Text] [Related]
13. Mapping a conserved conformational epitope from the M protein of group A streptococci.
Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF
Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479
[TBL] [Abstract][Full Text] [Related]
14. [Primary prevention of rheumatism: the status and outlook (vaccine)].
Rotta Y
Ter Arkh; 1985; 57(11):97-100. PubMed ID: 3909476
[No Abstract] [Full Text] [Related]
15. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.
Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF
Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155
[TBL] [Abstract][Full Text] [Related]
16. Application of immunoproteomics to analysis of post-translational processing of the antiphagocytic M protein of Streptococcus.
Romer TG; Boyle MD
Proteomics; 2003 Jan; 3(1):29-35. PubMed ID: 12548631
[TBL] [Abstract][Full Text] [Related]
17. Binding of human plasma proteins to Streptococcus pyogenes M protein determines the location of opsonic and non-opsonic epitopes.
Sandin C; Carlsson F; Lindahl G
Mol Microbiol; 2006 Jan; 59(1):20-30. PubMed ID: 16359315
[TBL] [Abstract][Full Text] [Related]
18. Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera.
Villaseñor-Sierra A; McShan WM; Salmi D; Kaplan EL; Johnson DR; Stevens DL
J Infect Dis; 1999 Dec; 180(6):1921-8. PubMed ID: 10558949
[TBL] [Abstract][Full Text] [Related]
19. Toward the development of a synthetic group a streptococcal vaccine of high purity and broad protective coverage.
Horváth A; Olive C; Karpati L; Sun HK; Good M; Toth I
J Med Chem; 2004 Jul; 47(16):4100-4. PubMed ID: 15267249
[TBL] [Abstract][Full Text] [Related]
20. Streptococcal vaccines revisited.
Stollerman GH
J Lab Clin Med; 1978 Jun; 91(6):872-80. PubMed ID: 77303
[No Abstract] [Full Text] [Related]
[Next] [New Search]
